{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:39Z","timestamp":1789635759171,"version":"4.0.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06199-8","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:17:11Z","timestamp":1789633031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Roles of Transcription Factor\u00a0Ets-1 in Neurological Disorders"],"prefix":"10.1007","volume":"63","author":[{"given":"Nattinee","family":"Jantaratnotai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"McLarnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"6199_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-4598-2-29","volume":"2","author":"J Dittmer","year":"2003","unstructured":"Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2:29. https:\/\/doi.org\/10.1186\/1476-4598-2-29","journal-title":"Mol Cancer"},{"key":"6199_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35099076","volume":"2","author":"AD Sharrocks","year":"2001","unstructured":"Sharrocks AD (2001) The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2:827\u2013837. https:\/\/doi.org\/10.1038\/35099076","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6199_CR3","doi-asserted-by":"publisher","unstructured":"Yang Y, Han X, Sun L, Shao F, Yin Y, Zhang W (2024) ETS Transcription Factors in Immune Cells and Immune-Related Diseases. Int J Mol Sci 25 https:\/\/doi.org\/10.3390\/ijms251810004","DOI":"10.3390\/ijms251810004"},{"key":"6199_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00005-006-0017-z","volume":"54","author":"S Gallant","year":"2006","unstructured":"Gallant S, Gilkeson G (2006) ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz) 54:149\u2013163. https:\/\/doi.org\/10.1007\/s00005-006-0017-z","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"6199_CR5","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s00018-012-1243-7","volume":"70","author":"LA Garrett-Sinha","year":"2013","unstructured":"Garrett-Sinha LA (2013) Review of Ets1 structure, function, and roles in immunity. Cell Mol Life Sci 70:3375\u20133390. https:\/\/doi.org\/10.1007\/s00018-012-1243-7","journal-title":"Cell Mol Life Sci"},{"key":"6199_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1526368","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Wan L, Zhang X, Fang H, Zhang M, Li F, Yan D (2025) ETS-1 in tumor immunology: implications for novel anti-cancer strategies. Front Immunol 16:1526368. https:\/\/doi.org\/10.3389\/fimmu.2025.1526368","journal-title":"Front Immunol"},{"key":"6199_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JAD-122191","volume":"37","author":"N Jantaratnotai","year":"2013","unstructured":"Jantaratnotai N, Ling A, Cheng J, Schwab C, McGeer PL, McLarnon JG (2013) Upregulation and expression patterns of the angiogenic transcription factor ets-1 in Alzheimer\u2019s disease brain. J Alzheimers Dis 37:367\u2013377. https:\/\/doi.org\/10.3233\/JAD-122191","journal-title":"J Alzheimers Dis"},{"key":"6199_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2007.05.019","volume":"188","author":"I Gerhauser","year":"2007","unstructured":"Gerhauser I, Alldinger S, Baumgartner W (2007) Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J Neuroimmunol 188:86\u201394. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.05.019","journal-title":"J Neuroimmunol"},{"key":"6199_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41419-022-04888-5","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang H, Wan Y, Yang S, Wu J, Chen S, Li Y, Jin H, et al. (2022) Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition. Cell Death Dis 13:462. https:\/\/doi.org\/10.1038\/s41419-022-04888-5","journal-title":"Cell Death Dis"},{"key":"6199_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117521","volume":"180","author":"Q Lu","year":"2024","unstructured":"Lu Q, Ma J, Zhao Y, Ding G, Wang Y, Qiao X, Cheng X (2024) Disruption of blood-brain barrier and endothelial-to-mesenchymal transition are attenuated by Astragalus polysaccharides mediated through upregulation of ETS1 expression in experimental autoimmune encephalomyelitis. Biomed Pharmacother 180:117521. https:\/\/doi.org\/10.1016\/j.biopha.2024.117521","journal-title":"Biomed Pharmacother"},{"key":"6199_CR11","doi-asserted-by":"publisher","unstructured":"Alruwaili M, Al-Kuraishy HM, Alexiou A, Papadakis M, BM AL, Elhussieny O, Saad HM, Batiha GE (2023) Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears. Neurochem Res 48 3255\u201369. https:\/\/doi.org\/10.1007\/s11064-023-03981-1","DOI":"10.1007\/s11064-023-03981-1"},{"key":"6199_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1247\/csf.26.19","volume":"26","author":"Y Sato","year":"2001","unstructured":"Sato Y (2001) Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct 26:19\u201324. https:\/\/doi.org\/10.1247\/csf.26.19","journal-title":"Cell Struct Funct"},{"key":"6199_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1349-7006.2004.tb03320.x","volume":"95","author":"T Oikawa","year":"2004","unstructured":"Oikawa T (2004) ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95:626\u2013633. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb03320.x","journal-title":"Cancer Sci"},{"key":"6199_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188872","volume":"1878","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huang Z, Sun M, Huang W, Xia L (2023) ETS transcription factors: multifaceted players from cancer progression to tumor immunity. Biochim Biophys Acta Rev Cancer 1878:188872. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188872","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6199_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0968-0004(92)90404-w","volume":"17","author":"K Macleod","year":"1992","unstructured":"Macleod K, Leprince D, Stehelin D (1992) The ets gene family. Trends Biochem Sci 17:251\u2013256. https:\/\/doi.org\/10.1016\/0968-0004(92)90404-w","journal-title":"Trends Biochem Sci"},{"key":"6199_CR16","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1038\/sj.onc.1204046","volume":"19","author":"DG Blair","year":"2000","unstructured":"Blair DG, Athanasiou M (2000) Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis. Oncogene 19:6472\u20136481. https:\/\/doi.org\/10.1038\/sj.onc.1204046","journal-title":"Oncogene"},{"key":"6199_CR17","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1073\/pnas.82.21.7294","volume":"82","author":"DK Watson","year":"1985","unstructured":"Watson DK, McWilliams-Smith MJ, Nunn MF, Duesberg PH, O\u2019Brien SJ, Papas TS (1985) The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active. Proc Natl Acad Sci U S A 82:7294\u20137298. https:\/\/doi.org\/10.1073\/pnas.82.21.7294","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6199_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.femsre.2004.12.008","volume":"29","author":"L Aravind","year":"2005","unstructured":"Aravind L, Anantharaman V, Balaji S, Babu MM, Iyer LM (2005) The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 29:231\u2013262. https:\/\/doi.org\/10.1016\/j.femsre.2004.12.008","journal-title":"FEMS Microbiol Rev"},{"key":"6199_CR19","doi-asserted-by":"publisher","unstructured":"Shiu YT, Jaimes EA (2018) Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury. Antioxidants (Basel) 7. https:\/\/doi.org\/10.3390\/antiox7070084","DOI":"10.3390\/antiox7070084"},{"key":"6199_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2015.09.010","volume":"35","author":"J Dittmer","year":"2015","unstructured":"Dittmer J (2015) The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol 35:20\u201338. https:\/\/doi.org\/10.1016\/j.semcancer.2015.09.010","journal-title":"Semin Cancer Biol"},{"key":"6199_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjh.19018","volume":"203","author":"EYL Chung","year":"2023","unstructured":"Chung EYL, Sartori G, Ponzoni M, Cascione L, Priebe V, Xu-Monette ZY, Fang X, Zhang M et al (2023) ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. Br J Haematol 203:244\u2013254. https:\/\/doi.org\/10.1111\/bjh.19018","journal-title":"Br J Haematol"},{"key":"6199_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P","volume":"176","author":"K Tanaka","year":"1998","unstructured":"Tanaka K, Oda N, Iwasaka C, Abe M, Sato Y (1998) Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol 176:235\u2013244. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199808)176:2%3c235::AID-JCP2%3e3.0.CO;2-P","journal-title":"J Cell Physiol"},{"key":"6199_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC (2025) NF-kappaB in inflammation and cancer. Cell Mol Immunol 22:811\u2013839. https:\/\/doi.org\/10.1038\/s41423-025-01310-w","journal-title":"Cell Mol Immunol"},{"key":"6199_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/138955708785909934","volume":"8","author":"JC Hahne","year":"2008","unstructured":"Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S, Wernert N (2008) The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 8:1095\u20131105. https:\/\/doi.org\/10.2174\/138955708785909934","journal-title":"Mini Rev Med Chem"},{"key":"6199_CR25","doi-asserted-by":"publisher","unstructured":"Shim JW, Madsen JR (2018) VEGF Signaling in Neurological Disorders. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19010275","DOI":"10.3390\/ijms19010275"},{"key":"6199_CR26","first-page":"207","volume":"11","author":"Y Sato","year":"1998","unstructured":"Sato Y (1998) Transcription factor ETS-1 as a molecular target for angiogenesis inhibition. Hum Cell 11:207\u2013214","journal-title":"Hum Cell"},{"key":"6199_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.expneurol.2004.02.010","volume":"187","author":"SD Croll","year":"2004","unstructured":"Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, Kasselman LJ, Kintner J et al (2004) VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 187:388\u2013402. https:\/\/doi.org\/10.1016\/j.expneurol.2004.02.010","journal-title":"Exp Neurol"},{"key":"6199_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1523\/JNEUROSCI.2888-08.2009","volume":"29","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG (2009) Microglial VEGF receptor response is an integral chemotactic component in Alzheimer\u2019s disease pathology. J Neurosci 29:3\u201313. https:\/\/doi.org\/10.1523\/JNEUROSCI.2888-08.2009","journal-title":"J Neurosci"},{"key":"6199_CR29","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1161\/01.CIR.0000130643.41587.DB","volume":"109","author":"N Hashiya","year":"2004","unstructured":"Hashiya N, Jo N, Aoki M, Matsumoto K, Nakamura T, Sato Y, Ogata N, Ogihara T, et al. (2004) In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109:3035\u20133041. https:\/\/doi.org\/10.1161\/01.CIR.0000130643.41587.DB","journal-title":"Circulation"},{"key":"6199_CR30","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.7150\/jca.25082","volume":"9","author":"N Niu","year":"2018","unstructured":"Niu N, Yu C, Li L, Liu Q, Zhang W, Liang K, Zhu Y, Li J et al (2018) Dihydroartemisinin enhances VEGFR1 expression through up-regulation of ETS-1 transcription factor. J Cancer 9:3366\u20133372. https:\/\/doi.org\/10.7150\/jca.25082","journal-title":"J Cancer"},{"key":"6199_CR31","doi-asserted-by":"publisher","first-page":"25404","DOI":"10.1074\/jbc.M804349200","volume":"283","author":"D Dutta","year":"2008","unstructured":"Dutta D, Ray S, Vivian JL, Paul S (2008) Activation of the VEGFR1 chromatin domain: an angiogenic signal-ETS1\/HIF-2alpha regulatory axis. J Biol Chem 283:25404\u201325413. https:\/\/doi.org\/10.1074\/jbc.M804349200","journal-title":"J Biol Chem"},{"key":"6199_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/jcp.22175","volume":"224","author":"SH Heo","year":"2010","unstructured":"Heo SH, Choi YJ, Ryoo HM, Cho JY (2010) Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. J Cell Physiol 224:734\u2013742. https:\/\/doi.org\/10.1002\/jcp.22175","journal-title":"J Cell Physiol"},{"key":"6199_CR33","doi-asserted-by":"publisher","unstructured":"McLarnon JG (2021) A Leaky Blood-Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer's Disease. Antioxidants (Basel) 11. https:\/\/doi.org\/10.3390\/antiox11010102","DOI":"10.3390\/antiox11010102"},{"key":"6199_CR34","doi-asserted-by":"publisher","first-page":"1609997","DOI":"10.3389\/pore.2021.1609997","volume":"27","author":"J Tang","year":"2021","unstructured":"Tang J, Li Y, Liu B, Liang W, Hu S, Shi M, Zeng J, Li M, et al. (2021) Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma. Pathol Oncol Res 27:1609997. https:\/\/doi.org\/10.3389\/pore.2021.1609997","journal-title":"Pathol Oncol Res"},{"key":"6199_CR35","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.21873\/anticanres.12601","volume":"38","author":"D Koessinger","year":"2018","unstructured":"Koessinger D, Albrecht V, Faber F, Jaehnert I, Schichor C (2018) ETS-1 expression is hypoxia-independent in glioblastoma-derived endothelial and mesenchymal stem-like cells. Anticancer Res 38:3347\u20133355. https:\/\/doi.org\/10.21873\/anticanres.12601","journal-title":"Anticancer Res"},{"key":"6199_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1128\/MCB.15.2.925","volume":"15","author":"LF Fleischman","year":"1995","unstructured":"Fleischman LF, Holtzclaw L, Russell JT, Mavrothalassitis G, Fisher RJ (1995) Ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol 15:925\u2013931. https:\/\/doi.org\/10.1128\/MCB.15.2.925","journal-title":"Mol Cell Biol"},{"key":"6199_CR37","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/1097-0142(20001201)89:11<2292::aid-cncr18>3.0.co;2-0","volume":"89","author":"G Kitange","year":"2000","unstructured":"Kitange G, Tsunoda K, Anda T, Nakamura S, Yasunaga A, Naito S, Shibata S (2000) Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas. Cancer 89:2292\u20132300. https:\/\/doi.org\/10.1002\/1097-0142(20001201)89:11%3c2292::aid-cncr18%3e3.0.co;2-0","journal-title":"Cancer"},{"key":"6199_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00005072-199904000-00003","volume":"58","author":"M Nakada","year":"1999","unstructured":"Nakada M, Yamashita J, Okada Y, Sato H (1999) Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J Neuropathol Exp Neurol 58:329\u2013334. https:\/\/doi.org\/10.1097\/00005072-199904000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"6199_CR39","first-page":"771","volume":"15","author":"A Sahin","year":"2005","unstructured":"Sahin A, Velten M, Pietsch T, Knuefermann P, Okuducu AF, Hahne JC, Wernert N (2005) Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. Int J Mol Med 15:771\u2013776","journal-title":"Int J Mol Med"},{"key":"6199_CR40","first-page":"377","volume":"34","author":"A Sahin","year":"2009","unstructured":"Sahin A, Vercamer C, Kaminski A, Fuchs T, Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A et al (2009) Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes. Int J Oncol 34:377\u2013389","journal-title":"Int J Oncol"},{"key":"6199_CR41","first-page":"407","volume":"79","author":"G Kitange","year":"1999","unstructured":"Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S (1999) Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest 79:407\u2013416","journal-title":"Lab Invest"},{"key":"6199_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.23736\/S0390-5616.20.04969-3","volume":"67","author":"B Zhao","year":"2023","unstructured":"Zhao B, Sun J, Du K, Liang N, Sun J (2023) Sprouty 4 suppresses glioblastoma invasion by inhibiting ERK phosphorylation and ETS-1-induced matrix metalloproteinase-9. J Neurosurg Sci 67:121\u2013128. https:\/\/doi.org\/10.23736\/S0390-5616.20.04969-3","journal-title":"J Neurosurg Sci"},{"key":"6199_CR43","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2559.2006.02432.x","volume":"48","author":"AF Okuducu","year":"2006","unstructured":"Okuducu AF, Zils U, Michaelis SA, Michaelides S, von Deimling A (2006) Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48:836\u2013845. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02432.x","journal-title":"Histopathology"},{"key":"6199_CR44","first-page":"7985","volume":"61","author":"D Kita","year":"2001","unstructured":"Kita D, Takino T, Nakada M, Takahashi T, Yamashita J, Sato H (2001) Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer Res 61:7985\u20137991","journal-title":"Cancer Res"},{"key":"6199_CR45","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/j.1742-4658.2010.07603.x","volume":"277","author":"AA Shukla","year":"2010","unstructured":"Shukla AA, Jain M, Chauhan SS (2010) Ets-1\/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells. FEBS J 277:1861\u20131875. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07603.x","journal-title":"FEBS J"},{"key":"6199_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3760","volume":"14","author":"M Holderfield","year":"2014","unstructured":"Holderfield M, Deuker MM, McCormick F, McMahon M (2014) Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer 14:455\u2013467. https:\/\/doi.org\/10.1038\/nrc3760","journal-title":"Nat Rev Cancer"},{"key":"6199_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-019-0775-6","volume":"7","author":"L Gabler","year":"2019","unstructured":"Gabler L, Lotsch D, Kirchhofer D, van Schoonhoven S, Schmidt HM, Mayr L, Pirker C, Neumayer K et al (2019) TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)\/TERT promoter double-mutated glioma. Acta Neuropathol Commun 7:128. https:\/\/doi.org\/10.1186\/s40478-019-0775-6","journal-title":"Acta Neuropathol Commun"},{"key":"6199_CR48","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41467-018-05644-0","volume":"9","author":"X Xu","year":"2018","unstructured":"Xu X, Li Y, Bharath SR, Ozturk MB, Bowler MW, Loo BZL, Tergaonkar V, Song H (2018) Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1. Nat Commun 9:3183. https:\/\/doi.org\/10.1038\/s41467-018-05644-0","journal-title":"Nat Commun"},{"key":"6199_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s42003-023-04821-2","volume":"6","author":"N Sim","year":"2023","unstructured":"Sim N, Li Y (2023) NF-kappaB\/p52 augments ETS1 binding genome-wide to promote glioma progression. Commun Biol 6:445. https:\/\/doi.org\/10.1038\/s42003-023-04821-2","journal-title":"Commun Biol"},{"key":"6199_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13046-019-1474-7","volume":"38","author":"H Xu","year":"2019","unstructured":"Xu H, Zhao G, Zhang Y, Jiang H, Wang W, Zhao D, Yu H, Qi L (2019) Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. J Exp Clin Cancer Res 38:486. https:\/\/doi.org\/10.1186\/s13046-019-1474-7","journal-title":"J Exp Clin Cancer Res"},{"key":"6199_CR51","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1038\/sj.onc.1207155","volume":"22","author":"E Kim","year":"2003","unstructured":"Kim E, Gunther W, Yoshizato K, Meissner H, Zapf S, Nusing RM, Yamamoto H, Van Meir EG, et al. (2003) Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1. Oncogene 22:7716\u20137727. https:\/\/doi.org\/10.1038\/sj.onc.1207155","journal-title":"Oncogene"},{"key":"6199_CR52","first-page":"134","volume":"60","author":"H Yamamoto","year":"2000","unstructured":"Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweeley C, Leestma J, Mkrdichian E et al (2000) Beta 1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res 60:134\u2013142","journal-title":"Cancer Res"},{"key":"6199_CR53","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/0008-5472.CAN-09-2090","volume":"70","author":"CE Holterman","year":"2010","unstructured":"Holterman CE, Franovic A, Payette J, Lee S (2010) ETS-1 oncogenic activity mediated by transforming growth factor alpha. Cancer Res 70:730\u2013740. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2090","journal-title":"Cancer Res"},{"key":"6199_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/767384","author":"P Oettgen","year":"2010","unstructured":"Oettgen P (2010) The role of ets factors in tumor angiogenesis. J Oncol. https:\/\/doi.org\/10.1155\/2010\/767384","journal-title":"J Oncol"},{"key":"6199_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, Chanoch-Myers R, Mathewson ND, Myskiw C, Atta L, Bussema L, Eichhorn SW, Greenwald AC et al (2021) Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell 39:779\u2013792. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.002","journal-title":"Cancer Cell"},{"key":"6199_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2012.12.010","volume":"331","author":"UD Kahlert","year":"2013","unstructured":"Kahlert UD, Nikkhah G, Maciaczyk J (2013) Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 331:131\u2013138. https:\/\/doi.org\/10.1016\/j.canlet.2012.12.010","journal-title":"Cancer Lett"},{"key":"6199_CR57","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1172\/JCI84876","volume":"126","author":"M Huang","year":"2016","unstructured":"Huang M, Liu T, Ma P, Mitteer RA Jr., Zhang Z, Kim HJ, Yeo E, Zhang D et al (2016) C-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest 126:1801\u20131814. https:\/\/doi.org\/10.1172\/JCI84876","journal-title":"J Clin Invest"},{"key":"6199_CR58","first-page":"5608","volume":"59","author":"MM Valter","year":"1999","unstructured":"Valter MM, Hugel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T, Wernert N (1999) Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)\/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59:5608\u20135614","journal-title":"Cancer Res"},{"key":"6199_CR59","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/1878-0261.12903","volume":"15","author":"S Shaik","year":"2021","unstructured":"Shaik S, Maegawa S, Haltom AR, Wang F, Xiao X, Dobson T, Sharma A, Yang Y et al (2021) REST promotes ETS1-dependent vascular growth in medulloblastoma. Mol Oncol 15:1486\u20131506. https:\/\/doi.org\/10.1002\/1878-0261.12903","journal-title":"Mol Oncol"},{"key":"6199_CR60","doi-asserted-by":"publisher","unstructured":"(2024) 2024 Alzheimer's disease facts and figures. Alzheimers Dement 20 3708\u2013821 https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"6199_CR61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0197-4580(00)00124-x","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421. https:\/\/doi.org\/10.1016\/s0197-4580(00)00124-x","journal-title":"Neurobiol Aging"},{"key":"6199_CR62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE et al (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85:296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032","journal-title":"Neuron"},{"key":"6199_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25:270\u2013276. https:\/\/doi.org\/10.1038\/s41591-018-0297-y","journal-title":"Nat Med"},{"key":"6199_CR64","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/dneu.22274","volume":"75","author":"A Kumar","year":"2015","unstructured":"Kumar A, Thakur MK (2015) Epigenetic regulation of presenilin 1 and 2 in the cerebral cortex of mice during development. Dev Neurobiol 75:1165\u20131173. https:\/\/doi.org\/10.1002\/dneu.22274","journal-title":"Dev Neurobiol"},{"key":"6199_CR65","doi-asserted-by":"publisher","first-page":"24297","DOI":"10.1074\/jbc.274.34.24297","volume":"274","author":"M Pastorcic","year":"1999","unstructured":"Pastorcic M, Das HK (1999) An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene. J Biol Chem 274:24297\u201324307. https:\/\/doi.org\/10.1074\/jbc.274.34.24297","journal-title":"J Biol Chem"},{"key":"6199_CR66","doi-asserted-by":"publisher","first-page":"34938","DOI":"10.1074\/jbc.M005411200","volume":"275","author":"M Pastorcic","year":"2000","unstructured":"Pastorcic M, Das HK (2000) Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene. J Biol Chem 275:34938\u201334945. https:\/\/doi.org\/10.1074\/jbc.M005411200","journal-title":"J Biol Chem"},{"key":"6199_CR67","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1582-4934.2008.00274.x","volume":"12","author":"ME Boulton","year":"2008","unstructured":"Boulton ME, Cai J, Grant MB (2008) Gamma-secretase: a multifaceted regulator of angiogenesis. J Cell Mol Med 12:781\u2013795. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00274.x","journal-title":"J Cell Mol Med"},{"key":"6199_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100857","volume":"59","author":"Z Huang","year":"2020","unstructured":"Huang Z, Wong LW, Su Y, Huang X, Wang N, Chen H, Yi C (2020) Blood-brain barrier integrity in the pathogenesis of Alzheimer\u2019s disease. Front Neuroendocrinol 59:100857. https:\/\/doi.org\/10.1016\/j.yfrne.2020.100857","journal-title":"Front Neuroendocrinol"},{"key":"6199_CR69","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/01.wnr.0000130539.39937.1d","volume":"15","author":"AI Pogue","year":"2004","unstructured":"Pogue AI, Lukiw WJ (2004) Angiogenic signaling in Alzheimer\u2019s disease. NeuroReport 15:1507\u20131510. https:\/\/doi.org\/10.1097\/01.wnr.0000130539.39937.1d","journal-title":"NeuroReport"},{"key":"6199_CR70","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","volume":"116","author":"BS Desai","year":"2009","unstructured":"Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B (2009) Evidence of angiogenic vessels in Alzheimer\u2019s disease. J Neural Transm 116:587\u2013597. https:\/\/doi.org\/10.1007\/s00702-009-0226-9","journal-title":"J Neural Transm"},{"key":"6199_CR71","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/jad-2006-10114","volume":"10","author":"L Thirumangalakudi","year":"2006","unstructured":"Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P (2006) Angiogenic proteins are expressed by brain blood vessels in Alzheimer\u2019s disease. J Alzheimers Dis 10:111\u2013118. https:\/\/doi.org\/10.3233\/jad-2006-10114","journal-title":"J Alzheimers Dis"},{"key":"6199_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023789","volume":"6","author":"KE Biron","year":"2011","unstructured":"Biron KE, Dickstein DL, Gopaul R, Jefferies WA (2011) Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer\u2019s disease. PLoS ONE 6:e23789. https:\/\/doi.org\/10.1371\/journal.pone.0023789","journal-title":"PLoS ONE"},{"key":"6199_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00001756-200502080-00011","volume":"16","author":"L Zand","year":"2005","unstructured":"Zand L, Ryu JK, McLarnon JG (2005) Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus. NeuroReport 16:129\u2013132. https:\/\/doi.org\/10.1097\/00001756-200502080-00011","journal-title":"NeuroReport"},{"key":"6199_CR74","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1073\/pnas.0709788105","volume":"105","author":"EP Meyer","year":"2008","unstructured":"Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T (2008) Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 105:3587\u20133592. https:\/\/doi.org\/10.1073\/pnas.0709788105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6199_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.811210","volume":"13","author":"A Custodia","year":"2021","unstructured":"Custodia A, Ouro A, Romaus-Sanjurjo D, Pias-Peleteiro JM, de Vries HE, Castillo J, Sobrino T (2021) Endothelial progenitor cells and vascular alterations in Alzheimer\u2019s disease. Front Aging Neurosci 13:811210. https:\/\/doi.org\/10.3389\/fnagi.2021.811210","journal-title":"Front Aging Neurosci"},{"key":"6199_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13061","volume":"32","author":"RA Fisher","year":"2022","unstructured":"Fisher RA, Miners JS, Love S (2022) Pathological changes within the cerebral vasculature in Alzheimer\u2019s disease: new perspectives. Brain Pathol 32:e13061. https:\/\/doi.org\/10.1111\/bpa.13061","journal-title":"Brain Pathol"},{"key":"6199_CR77","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1567205011310030004","volume":"10","author":"JK Ryu","year":"2013","unstructured":"Ryu JK, Little JP, Klegeris A, Jantaratnotai N, McLarnon JG (2013) Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer\u2019s disease. Curr Alzheimer Res 10:252\u2013260. https:\/\/doi.org\/10.2174\/1567205011310030004","journal-title":"Curr Alzheimer Res"},{"key":"6199_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103503","volume":"71","author":"CSB Singh","year":"2021","unstructured":"Singh CSB, Choi KB, Munro L, Wang HY, Pfeifer CG, Jefferies WA (2021) Reversing pathology in a preclinical model of Alzheimer\u2019s disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. EBioMedicine 71:103503. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103503","journal-title":"EBioMedicine"},{"key":"6199_CR79","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBDRF Collaborators","year":"2020","unstructured":"Collaborators GBDRF (2020) Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1223\u20131249. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2","journal-title":"Lancet"},{"key":"6199_CR80","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM et al (2025) 2025 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circ 151:e41\u2013e660. https:\/\/doi.org\/10.1161\/CIR.0000000000001303","journal-title":"Circ"},{"key":"6199_CR81","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","volume":"25","author":"R Virmani","year":"2005","unstructured":"Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054\u20132061. https:\/\/doi.org\/10.1161\/01.ATV.0000178991.71605.18","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6199_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32692","volume":"10","author":"Q Chai","year":"2024","unstructured":"Chai Q, Guo C, Li L, Cao J, Liu H, Lu Z (2024) Association of angiogenesis-associated genes with atherosclerotic plaque progression, intraplaque hemorrhage, and immune infiltration. Heliyon 10:e32692. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32692","journal-title":"Heliyon"},{"key":"6199_CR83","doi-asserted-by":"publisher","first-page":"13103","DOI":"10.1016\/S0021-9258(18)37677-4","volume":"263","author":"TP Hausner","year":"1988","unstructured":"Hausner TP, Geigenmuller U, Nierhaus KH (1988) The allosteric three-site model for the ribosomal elongation cycle. New insights into the inhibition mechanisms of aminoglycosides, thiostrepton, and viomycin. J Biol Chem 263:13103\u201313111","journal-title":"J Biol Chem"},{"key":"6199_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3171\/JNS\/2008\/109\/7\/0083","volume":"109","author":"T Higashida","year":"2008","unstructured":"Higashida T, Kanno H, Nakano M, Funakoshi K, Yamamoto I (2008) Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis. J Neurosurg 109:83\u201391. https:\/\/doi.org\/10.3171\/JNS\/2008\/109\/7\/0083","journal-title":"J Neurosurg"},{"key":"6199_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2012.11.052","volume":"1495","author":"JV Pulliam","year":"2013","unstructured":"Pulliam JV, Xu Z, Ford GD, Liu C, Li Y, Stovall KC, Cannon VS, Tewolde T, et al. (2013) Computational identification of conserved transcription factor binding sites upstream of genes induced in rat brain by transient focal ischemic stroke. Brain Res 1495:76\u201385. https:\/\/doi.org\/10.1016\/j.brainres.2012.11.052","journal-title":"Brain Res"},{"key":"6199_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197092","volume":"13","author":"MC Surles-Zeigler","year":"2018","unstructured":"Surles-Zeigler MC, Li Y, Distel TJ, Omotayo H, Ge S, Ford BD (2018) Transcriptomic analysis of neuregulin-1 regulated genes following ischemic stroke by computational identification of promoter binding sites: a role for the ETS-1 transcription factor. PLoS ONE 13:e0197092. https:\/\/doi.org\/10.1371\/journal.pone.0197092","journal-title":"PLoS ONE"},{"key":"6199_CR87","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/gt.2010.60","volume":"17","author":"T Aoki","year":"2010","unstructured":"Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R, Miyamoto S (2010) Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Ther 17:1117\u20131123. https:\/\/doi.org\/10.1038\/gt.2010.60","journal-title":"Gene Ther"},{"key":"6199_CR88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169\u2013180. https:\/\/doi.org\/10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"6199_CR89","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"Collaborators GBDNSD","year":"2024","unstructured":"Collaborators GBDNSD (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23:344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"key":"6199_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1627","volume":"15","author":"LA Garrett-Sinha","year":"2023","unstructured":"Garrett-Sinha LA (2023) An update on the roles of transcription factor Ets1 in autoimmune diseases. WIREs Mech Dis 15:e1627. https:\/\/doi.org\/10.1002\/wsbm.1627","journal-title":"WIREs Mech Dis"},{"key":"6199_CR91","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/jmedgenet-2015-103442","volume":"52","author":"CM Lill","year":"2015","unstructured":"Lill CM, Luessi F, Alcina A, Sokolova EA, Ugidos N, de la Hera B, Guillot-Noel L, Malhotra S et al (2015) Genome-wide significant association with seven novel multiple sclerosis risk loci. J Med Genet 52:848\u2013855. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103442","journal-title":"J Med Genet"},{"key":"6199_CR92","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1084\/jem.20041330","volume":"201","author":"R Grenningloh","year":"2005","unstructured":"Grenningloh R, Kang BY, Ho IC (2005) Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 201:615\u2013626. https:\/\/doi.org\/10.1084\/jem.20041330","journal-title":"J Exp Med"},{"key":"6199_CR93","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.164.6.2857","volume":"164","author":"TL Walunas","year":"2000","unstructured":"Walunas TL, Wang B, Wang CR, Leiden JM (2000) Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol 164:2857\u20132860. https:\/\/doi.org\/10.4049\/jimmunol.164.6.2857","journal-title":"J Immunol"},{"key":"6199_CR94","doi-asserted-by":"publisher","first-page":"12480","DOI":"10.1128\/JVI.78.22.12480-12488.2004","volume":"78","author":"M Trottier","year":"2004","unstructured":"Trottier M, Schlitt BP, Kung AY, Lipton HL (2004) Transition from acute to persistent Theiler\u2019s virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J Virol 78:12480\u201312488. https:\/\/doi.org\/10.1128\/JVI.78.22.12480-12488.2004","journal-title":"J Virol"},{"key":"6199_CR95","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/01.jnen.0000229990.32795.0d","volume":"65","author":"R Ulrich","year":"2006","unstructured":"Ulrich R, Baumgartner W, Gerhauser I, Seeliger F, Haist V, Deschl U, Alldinger S (2006) MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. J Neuropathol Exp Neurol 65:783\u2013793. https:\/\/doi.org\/10.1097\/01.jnen.0000229990.32795.0d","journal-title":"J Neuropathol Exp Neurol"},{"key":"6199_CR96","doi-asserted-by":"publisher","unstructured":"Li L, Ma X, Zhao YF, Zhang C (2020) MiR-1\u20133p facilitates Th17 differentiation associating with multiple sclerosis via targeting ETS1. Eur Rev Med Pharmacol Sci 24:6881\u201392 https:\/\/doi.org\/10.26355\/eurrev_202006_21678","DOI":"10.26355\/eurrev_202006_21678"},{"key":"6199_CR97","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.msard.2017.09.003","volume":"18","author":"YF Li","year":"2017","unstructured":"Li YF, Zhang SX, Ma XW, Xue YL, Gao C, Li XY (2017) Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 18:20\u201325. https:\/\/doi.org\/10.1016\/j.msard.2017.09.003","journal-title":"Mult Scler Relat Disord"},{"key":"6199_CR98","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman A, Hauptmann J, Regen T (2015) The role of IL-17 in CNS diseases. Acta Neuropathol 129:625\u2013637. https:\/\/doi.org\/10.1007\/s00401-015-1402-7","journal-title":"Acta Neuropathol"},{"key":"6199_CR99","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"key":"6199_CR100","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11910-024-01339-w","volume":"24","author":"JR Deliz","year":"2024","unstructured":"Deliz JR, Tanner CM, Gonzalez-Latapi P (2024) Epidemiology of Parkinson\u2019s disease: an update. Curr Neurol Neurosci Rep 24:163\u2013179. https:\/\/doi.org\/10.1007\/s11910-024-01339-w","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6199_CR101","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20:1255\u20131263. https:\/\/doi.org\/10.1002\/mds.20527","journal-title":"Mov Disord"},{"key":"6199_CR102","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1001\/archneurol.2011.924","volume":"69","author":"Z Gan-Or","year":"2012","unstructured":"Gan-Or Z, Bar-Shira A, Dahary D, Mirelman A, Kedmi M, Gurevich T, Giladi N, Orr-Urtreger A (2012) Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol 69:105\u2013110. https:\/\/doi.org\/10.1001\/archneurol.2011.924","journal-title":"Arch Neurol"},{"key":"6199_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108921","volume":"27","author":"A Booms","year":"2024","unstructured":"Booms A, Pierce SE, van der Schans EJC, Coetzee GA (2024) Parkinson\u2019s disease risk enhancers in microglia. iScience 27:108921. https:\/\/doi.org\/10.1016\/j.isci.2024.108921","journal-title":"iScience"},{"key":"6199_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"6199_CR105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"B Desai Bradaric","year":"2012","unstructured":"Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B (2012) Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna) 119:59\u201371. https:\/\/doi.org\/10.1007\/s00702-011-0684-8","journal-title":"J Neural Transm (Vienna)"},{"key":"6199_CR106","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155:654\u2013662. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013","journal-title":"Pain"},{"key":"6199_CR107","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/187152412803760645","volume":"12","author":"JH Vranken","year":"2012","unstructured":"Vranken JH (2012) Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 12:304\u2013314. https:\/\/doi.org\/10.2174\/187152412803760645","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"6199_CR108","doi-asserted-by":"publisher","first-page":"174480692311521","DOI":"10.1177\/17448069231152125","volume":"19","author":"HL Zheng","year":"2023","unstructured":"Zheng HL, Sun SY, Jin T, Zhang M, Zeng Y, Liu Q, Yang K, Wei R, et al. (2023) Transcription factor ETS proto-oncogene 1 contributes to neuropathic pain by regulating histone deacetylase 1 in primary afferent neurons. Mol Pain 19:17448069231152124. https:\/\/doi.org\/10.1177\/17448069231152125","journal-title":"Mol Pain"},{"key":"6199_CR109","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiat 75:336\u2013346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4602","journal-title":"JAMA Psychiat"},{"key":"6199_CR110","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000318293","volume":"79","author":"HE Pigott","year":"2010","unstructured":"Pigott HE, Leventhal AM, Alter GS, Boren JJ (2010) Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 79:267\u2013279. https:\/\/doi.org\/10.1159\/000318293","journal-title":"Psychother Psychosom"},{"key":"6199_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101171","volume":"41","author":"F Alemi","year":"2021","unstructured":"Alemi F, Min H, Yousefi M, Becker LK, Hane CA, Nori VS, Wojtusiak J (2021) Effectiveness of common antidepressants: a post market release study. EClinicalMedicine 41:101171. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101171","journal-title":"EClinicalMedicine"},{"key":"6199_CR112","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00018-008-8160-9","volume":"65","author":"E Kuteeva","year":"2008","unstructured":"Kuteeva E, Hokfelt T, Wardi T, Ogren SO (2008) Galanin, galanin receptor subtypes and depression-like behaviour. Cell Mol Life Sci 65:1854\u20131863. https:\/\/doi.org\/10.1007\/s00018-008-8160-9","journal-title":"Cell Mol Life Sci"},{"key":"6199_CR113","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-006-0336-8","volume":"31","author":"RM Karlsson","year":"2006","unstructured":"Karlsson RM, Holmes A (2006) Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease. Amino Acids 31:231\u2013239. https:\/\/doi.org\/10.1007\/s00726-006-0336-8","journal-title":"Amino Acids"},{"key":"6199_CR114","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.npep.2008.04.009","volume":"42","author":"X Lu","year":"2008","unstructured":"Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T (2008) Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides 42:387\u2013397. https:\/\/doi.org\/10.1016\/j.npep.2008.04.009","journal-title":"Neuropeptides"},{"key":"6199_CR115","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuroscience.2011.05.015","volume":"190","author":"TW Le Maitre","year":"2011","unstructured":"Le Maitre TW, Xia S, Le Maitre E, Dun XP, Lu J, Theodorsson E, Ogren SO, Hokfelt T, et al. (2011) Galanin receptor 2 overexpressing mice display an antidepressive-like phenotype: possible involvement of the subiculum. Neuroscience 190:270\u2013288. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.05.015","journal-title":"Neuroscience"},{"key":"6199_CR116","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1007\/s12035-016-9986-z","volume":"54","author":"Y Yang","year":"2017","unstructured":"Yang Y, Liu L, Luo H, Li Y, Li H, Xu ZD (2017) Characterization of the rat GAL2R promoter: positive role of ETS-1 in regulation of the rat GAL2R gene in PC12 cells. Mol Neurobiol 54:4421\u20134431. https:\/\/doi.org\/10.1007\/s12035-016-9986-z","journal-title":"Mol Neurobiol"},{"key":"6199_CR117","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s12264-019-00412-6","volume":"35","author":"H Luo","year":"2019","unstructured":"Luo H, Liu Z, Liu B, Li H, Yang Y, Xu ZD (2019) Virus-mediated overexpression of ETS-1 in the ventral hippocampus counteracts depression-like behaviors in rats. Neurosci Bull 35:1035\u20131044. https:\/\/doi.org\/10.1007\/s12264-019-00412-6","journal-title":"Neurosci Bull"},{"key":"6199_CR118","doi-asserted-by":"publisher","first-page":"E8472","DOI":"10.1073\/pnas.1617824113","volume":"113","author":"S Barde","year":"2016","unstructured":"Barde S, Ruegg J, Prud\u2019homme J, Ekstrom TJ, Palkovits M, Turecki G, Bagdy G, Ihnatko R et al (2016) Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide. Proc Natl Acad Sci U S A 113:E8472\u2013E8481. https:\/\/doi.org\/10.1073\/pnas.1617824113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6199_CR119","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2147\/NDT.S140634","volume":"13","author":"C Luo","year":"2017","unstructured":"Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y (2017) The role of microglia in multiple sclerosis. Neuropsychiatr Dis Treat 13:1661\u20131667. https:\/\/doi.org\/10.2147\/NDT.S140634","journal-title":"Neuropsychiatr Dis Treat"},{"key":"6199_CR120","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.24501","volume":"72","author":"AM Planas","year":"2024","unstructured":"Planas AM (2024) Role of microglia in stroke. Glia 72:1016\u20131053. https:\/\/doi.org\/10.1002\/glia.24501","journal-title":"Glia"},{"key":"6199_CR121","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","volume":"3","author":"Z Liu","year":"2022","unstructured":"Liu Z, Hu M, Yang Y, Du C, Zhou H, Liu C, Chen Y, Fan L et al (2022) An overview of PROTACs: a promising drug discovery paradigm. Mol Biomed 3:46. https:\/\/doi.org\/10.1186\/s43556-022-00112-0","journal-title":"Mol Biomed"},{"key":"6199_CR122","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jmb.2018.06.037","volume":"431","author":"X Xu","year":"2019","unstructured":"Xu X, Qi LS (2019) A CRISPR-dCas toolbox for genetic engineering and synthetic biology. J Mol Biol 431:34\u201347. https:\/\/doi.org\/10.1016\/j.jmb.2018.06.037","journal-title":"J Mol Biol"},{"key":"6199_CR123","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1177\/0271678X241305914","volume":"46","author":"R Shi","year":"2026","unstructured":"Shi R, Chen H, Zhang W, Leak RK, Lou D, Chen K, Chen J (2026) Single-cell RNA sequencing in stroke and traumatic brain injury: current achievements, challenges and future perspectives on transcriptomic profiling. J Cereb Blood Flow Metab 46:1447\u20131471. https:\/\/doi.org\/10.1177\/0271678X241305914","journal-title":"J Cereb Blood Flow Metab"},{"key":"6199_CR124","doi-asserted-by":"publisher","unstructured":"Gadani SP, Singh S, Kim S, Hu J, Smith MD, Calabresi PA, Bhargava P (2024) Spatial transcriptomics of meningeal inflammation reveals inflammatory gene signatures in adjacent brain parenchyma. Elife 12. https:\/\/doi.org\/10.7554\/eLife.88414","DOI":"10.7554\/eLife.88414"},{"key":"6199_CR125","doi-asserted-by":"publisher","first-page":"25910","DOI":"10.1039\/d5ra03578c","volume":"15","author":"D Senanayake","year":"2025","unstructured":"Senanayake D, Yapa P, Dabare S, Munaweera I (2025) Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery. RSC Adv 15:25910\u201325928. https:\/\/doi.org\/10.1039\/d5ra03578c","journal-title":"RSC Adv"},{"key":"6199_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-026-03603-6","author":"TT Zhu","year":"2026","unstructured":"Zhu TT, Liu PM, Hashimoto K, Yang JJ (2026) Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-026-03603-6","journal-title":"Mol Psychiatry"},{"key":"6199_CR127","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY (2018) Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17:641\u2013659. https:\/\/doi.org\/10.1038\/nrd.2018.110","journal-title":"Nat Rev Drug Discov"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06199-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06199-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06199-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:17:13Z","timestamp":1789633033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06199-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6199"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06199-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"903"}}